Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC11561 NSC 95397

    Cdc25 Inhibitor IV, PTP Inhibitor XXIX

    An irreversible inhibitor of Cdc25 isoforms
  3. GC11559 Anisomycin

    茴香霉素; Flagecidin; Wuningmeisu C

    Anisomycin是一种从灰链霉菌中分离出来的抗生素,也是一种JNK激活剂。
  4. GC10567 TCPOBOP An agonist for mouse CAR
  5. GC17394 3-Nitropropionic acid

    3-硝基丙酸; β-Nitropropionic acid; Bovinocidin

    An inhibitor of complex II
  6. GC16775 Rotenone

    鱼藤酮

    Rotenone是一种线粒体电子传递链复合物 I 抑制剂,可通过增强线粒体活性氧的产生来诱导细胞凋亡。
  7. GC15148 Ionomycin calcium salt

    罗红霉素钙盐(链霉菌属载体),SQ23377 calcium

    Ionomycin calcium salt是一种窄谱抗生素,对革兰氏阳性菌具有活性,由丛生链霉菌(Streptomyces conglobatus)产生。
  8. GC14731 MTT

    噻唑蓝,MTT; Thiazolyl Blue Tetrazolium bromide; Methylthiazolyldiphenyl-tetrazolium bromide

    A cell-permeable and positively charged tetrazolium dye

  9. GC14228 Propidium iodide

    碘化丙啶; PI

    A fluorescent probe used to identify dead cells

  10. GC16516 BCH

    2-氨基-2-去甲菠烷羧酸,2-amino-2-Norbornanecarboxylic Acid

    An inhibitor of LAT1
  11. GC11040 Borrelidin

    疏螺旋体素,Treponemycin

    An antiangiogenic antibiotic
  12. GC11459 Xanthurenic acid

    4,8-二羟基喹啉-2-甲酸

    Xanthurenic acid是一种内源性II组代谢型谷氨酸受体激动剂,参与丘脑的感觉传递。
  13. GC14203 Citric acid

    柠檬酸

    柠檬酸是一种天然防腐剂和食品酸味增强剂。
  14. GC13292 EGTA

    乙二醇双(2-氨基乙基醚)四乙酸

    A chelating agent
  15. GC16795 DCA

    二氯乙酸钠

    DCA 是癌细胞中的代谢调节剂';具有抗癌活性的线粒体。 DCA 抑制 PDHK,导致肿瘤微环境中的乳酸减少。 DCA 增加活性氧 (ROS) 生成并促进癌细胞凋亡。 DCA 也可作为 NKCC 抑制剂。
  16. GC12090 Nonactin

    无活菌素; Ammonium ionophore I

    A mixture of macrotetralide antibiotics that act as ionophores
  17. GC15446 Ionomycin free acid

    离子霉素,SQ23377

    Ionomycin free acid 是一种选择性的强效钙离子载体,可作为活性 Ca2+ 载体。
  18. GC15211 Damnacanthal Damnacanthal 是一种从海巴戟根中分离出来的蒽醌。
  19. GC16673 N-Formyl-Met-Leu-Phe

    酪胺盐酸盐,fMLP; N-Formyl-MLF

    N-Formyl-Met-Leu-Phe是一种内源性趋化肽,也是甲酰肽受体1(FPR1)的激动剂,Ki值为38 nM。
  20. GC17346 KT 5823

    蛋白激酶仰制剂KT5823

    Potent selective inhibitor of cGMP-dependent protein kinase (PKG)

  21. GC11200 A23187

    离子载体(钙镁盐混合物),Calcimycin

    A23187自由酸是一种Ca2+离子载体。

  22. GC11482 Thapsigargin

    毒胡萝卜素

    他普西加林是一种肌浆网/内质网Ca2+ ATP酶泵的抑制剂。
  23. GC12718 Pantoprazole

    泮托拉唑; BY1023; SKF96022

    A proton pump inhibitor
  24. GC12647 NVP-CGM097

    CGM097

    An inhibitor of the MDM2-p53 interaction
  25. GC12333 BV6 A bivalent Smac mimetic and IAP antagonist
  26. GC15586 AP1903

    AP1903

    A CID for FKBPF36V fusion proteins
  27. GC12515 NMS-1286937

    4,5-二氢-1-(2-羟基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺,NMS-1286937; NMS-P937

    An inhibitor of Plk1
  28. GC10083 MPI-0479605 A potent inhibitor of MPS1
  29. GC15462 ISRIB (trans-isomer)

    ISRIB(TRANS-ISOMER)抑制剂

    An inhibitor of the Integrated Stress Response
  30. GC10468 4EGI-1

    eIF4E/eIF4G Interaction Inhibitor

    An inhibitor of mRNA translation
  31. GC13484 Griseofulvin

    灰黄霉素

    A fungal metabolite with antifungal and anticancer activities
  32. GC16237 Apocynin

    香草乙酮; Acetovanillone

    An acetophenone with antioxidant and anti-inflammatory activities
  33. GC12975 Indirubin

    靛玉红; Couroupitine B; Indigo red; Indigopurpurin

    A natural inhibitor of GSK3 and CDK isoforms
  34. GC14800 ML 141

    CID-2950007

    An allosteric Cdc42 inhibitor
  35. GC17960 U 73343 An inactive analog of U-73122
  36. GC12411 RHC 80267

    1,6-双(环己基脒基羰基氨基)己烷,U-57908

    An inhibitor of DAGL
  37. GC10501 VER-50589 Inhibitor of Hsp90
  38. GC16922 Kobe0065 A selective Ras inhibitor
  39. GC18133 ATB-346

    ATB-346

    An H2S-releasing NSAID
  40. GC17995 Tacrolimus monohydrate

    他克莫司一水合物; FK506 monohydrate; Fujimycin monohydrate; FR900506 monohydrate

    他克莫司一水合物 (FK506 monohydrate) 是一种大环内酯,与 FK506 结合蛋白 (FKBP) 结合形成复合物并抑制钙调神经磷酸酶,从而抑制 T 淋巴细胞信号转导和 IL-2 转录。
  41. GC13693 Omaveloxolone (RTA-408)

    RTA 408

    A synthetic triterpenoid that blocks Keap1/Nrf2 signaling
  42. GC15670 Rabeprazole sodium

    雷贝拉唑钠; LY307640 sodium

    A proton pump inhibitor
  43. GC10451 U-73122

    1-[6-[((17Β)-3-雌酮-1,3,5[10]-三烯-17-基)氨基]乙基]-1H-吡咯-2,5-二酮

    U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC50值约为1-2.1µM,也可抑制5-脂氧合酶(5-LO)。
  44. GC16843 Hydroxyurea

    羟基脲; Hydroxycarbamide

    An antineoplastic agent
  45. GC15775 Metronidazole

    甲硝唑

    An antibiotic

  46. GC12051 Amiloride HCl dihydrate

    盐酸阿米洛利二水合物; MK-870 hydrochloride dihydrate

    An Analytical Reference Standard
  47. GC12256 D-Mannitol

    D-甘露醇 ; Mannitol; Mannite

    An Analytical Reference Standard
  48. GC15857 Sodium butyrate

    丁酸钠

    A short-chain fatty acid and HDAC inhibitor
  49. GC12318 Candesartan Cilexetil

    坎地沙坦酯; TCV-116

    A prodrug form of candesartan
  50. GC11655 Moexipril HCl

    莫昔普利盐酸盐,RS-10085

    A prodrug form of moexiprilat
  51. GC15550 Lacidipine

    拉西地平

    An L-type calcium channel blocker

Items 2101 to 2150 of 2733 total

per page

Set Descending Direction